Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Michigan Rogel Cancer Center
University of Michigan Rogel Cancer Center
Incyte Corporation
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Merck Sharp & Dohme LLC
University of Chicago
University of Chicago
Thomas Jefferson University
AstraZeneca
University of Chicago
University of Chicago
M.D. Anderson Cancer Center
University Medical Center Groningen
Centre Leon Berard
Presage Biosciences
Cantargia AB
University of Chicago
Eastern Cooperative Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Michigan Rogel Cancer Center
AstraZeneca
UNC Lineberger Comprehensive Cancer Center
Groupe Oncologie Radiotherapie Tete et Cou
Celgene
Groupe Oncologie Radiotherapie Tete et Cou
Daiichi Sankyo
Jonsson Comprehensive Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Fox Chase Cancer Center
Massachusetts General Hospital
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
GERCOR - Multidisciplinary Oncology Cooperative Group
Emory University
Oncolytics Biotech
Oncolytics Biotech
SWOG Cancer Research Network
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Groupe Oncologie Radiotherapie Tete et Cou
National Cancer Institute (NCI)